Natural products for cancer-targeted therapy: citrus flavonoids as potent chemopreventive agents
Related Experiment Video
Updated: May 23, 2026

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
Edy Meiyanto1, Adam Hermawan, Anindyajati
1Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta. meiyan_e@ugm.ac.id
Abstract:
Targeted therapy has been a very promising strategy of drug development research. Many molecular mechanims of diseases have been known to be regulated by abundance of proteins, such as receptors and hormones. Chemoprevention for treatment and prevention of diseases are continuously developed. Pre-clinical and clinical studies in chemoprevention field yielded many valuable data in preventing the onset of disease and suppressing the progress of their growth, making chemoprevention a challenging and a very rational strategy in future researches. Natural products being rich of flavonoids are those fruits belong to the genus citrus. Ethanolic extract of Citrus reticulata and Citrus aurantiifolia peels showed anticarcinogenic, antiproliferative, co-chemotherapeutic and estrogenic effects. Several examples of citrus flavonoids that are potential as chemotherapeutic agents are tangeretin, nobiletin, hesperetin, hesperidin, naringenin, and naringin. Those flavonoids have been shown to possess inhibition activity on certain cancer cells' growth through various mechanisms. Moreover, citrus flavonoids also perform promising effect in combination with several chemotherapeutic agents against the growth of cancer cells. Some mechanisms involved in those activities are through cell cycle modulation, antiangiogenic effect, and apoptosis induction. Previous studies showed that tangeretin suppressed the growth of T47D breast cancer cells by inhibiting ERK phosphorylation. While in combination with tamoxifen, doxorubicin, and 5-FU, respectively, it was proven to be synergist on several cancer cells. Hesperidin and naringenin increased cytotoxicitity of doxorubicin on MCF-7 cells and HeLa cells. Besides, citrus flavonoids also performed estrogenic effect in vivo. One example is hesperidin having the ability to decrease the concentration of serum and hepatic lipid and reduce osteoporosis of ovariectomized rats. Those studies showed the great potential of citrus fruits as natural product to be developed as not only the source of co-chemotherapeutic agents, but also phyto-estrogens. Therefore, further study needs to be conducted to explore the potential of citrus fruits in overcoming cancer.
Insights
Citrus flavonoids show promise as natural chemopreventive agents, exhibiting anticancer and estrogenic effects. These compounds can inhibit cancer cell growth and enhance chemotherapy efficacy, highlighting their potential in cancer treatment.
Area of Science:
- Pharmacology
- Natural Products Chemistry
- Oncology
Background:
- Targeted therapy and chemoprevention are crucial in disease management.
- Natural products, particularly citrus flavonoids, are explored for therapeutic potential.
- Citrus fruits contain flavonoids with documented anticarcinogenic and antiproliferative activities.
Purpose of the Study:
- To review the chemopreventive and therapeutic potential of citrus flavonoids.
- To explore their mechanisms of action in cancer treatment.
- To highlight their role as co-chemotherapeutic agents and phytoestrogens.
Main Methods:
- Review of pre-clinical and clinical studies on citrus flavonoids.
- Analysis of in vitro and in vivo experimental data.
- Examination of molecular mechanisms including cell cycle modulation, antiangiogenesis, and apoptosis.
Main Results:
- Ethanolic extracts of Citrus reticulata and Citrus aurantiifolia peels exhibit anticarcinogenic, antiproliferative, and estrogenic effects.
- Specific flavonoids like tangeretin, nobiletin, hesperetin, hesperidin, naringenin, and naringin inhibit cancer cell growth.
- Citrus flavonoids demonstrate synergistic effects when combined with conventional chemotherapeutic agents (e.g., tamoxifen, doxorubicin, 5-FU).
- Hesperidin showed lipid-lowering and osteoporosis-reducing effects in vivo.
Conclusions:
- Citrus flavonoids possess significant potential as natural co-chemotherapeutic agents.
- Their anticancer activities are mediated through diverse mechanisms, including apoptosis induction and cell cycle arrest.
- Citrus flavonoids also exhibit beneficial estrogenic effects, suggesting dual therapeutic applications.
- Further research is warranted to fully develop citrus-derived compounds for cancer therapy.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Inhibition of Cdk Activity
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
